Navigation Links
Lilly CEO Says Industry, Public Policy Must Pave Way For Innovation
Date:2/10/2011

LONDON, Feb. 10, 2011 /PRNewswire/ -- A new approach to research, along with public policies that support medical innovation, will help biopharmaceutical companies address stubborn diseases with potentially devastating personal and financial consequences, such as cancer and Alzheimer's disease, according to John Lechleiter, Ph.D., chairman, president and CEO of Eli Lilly and Company (NYSE: LLY).

Lechleiter made his remarks Thursday in London during a keynote address at The Economist's 2011 Pharma Summit: Reinventing Pharma for a New Generation. During his talk, Lechleiter said two imperatives are needed to secure the future of the research-based pharmaceutical industry: changing the way companies conduct research, and public policies that promote an environment in which medical innovation can flourish.

The burden of several diseases is soaring in many countries, including the U.K.

According to the Alzheimer's Research Trust, for instance, more than 800,000 people in the U.K. are directly affected by dementia at a cost of 23 billion pounds Sterling per year.

And yet, just when the world desperately needs more new medicines for diseases like Alzheimer's, "our industry is taking too long, we're spending too much, and we're producing far too little," Lechleiter told the audience.

Lechleiter said the case for biopharmaceutical research and new medications is compelling. Specifically, he noted that:

  • Innovative medicines have proven themselves time and again to be the most effective way to reduce costs and improve quality in health care.
  • Treatments for diseases that remain unconquered, like cancer and Alzheimer's, most likely will come from laboratories of biopharmaceutical companies.
  • Even diseases that are being treated today, like diabetes, require better solutions.

"Ironically, the crisis in our innovation model comes at a time when we have vastly more s
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lilly and the Juvenile Diabetes Research Foundation Partner to Fund Regenerative Medicine Research in Type 1 Diabetes
2. Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab
3. Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance
4. Statement from Lilly and Avid on FDA Advisory Committee Recommendation for Amyvid™ (Florbetapir) NDA
5. Cognizant Selected by Lilly to Deliver Commercial Operations Solutions to Enhance Sales and Marketing Effectiveness, Business Performance
6. Lilly Confirms Date and Conference Call for Fourth-Quarter and Full-Year 2010 Financial Results Announcement
7. Statement From Lilly on FDA Advisory Committee Recommendation Regarding Liprotamase New Drug Application for Treatment of Exocrine Pancreatic Insufficiency
8. Lilly Announces Completion of Avid Acquisition and FDA Priority Review for florbetapir
9. Manchester College Receives $35 Million Grant From Lilly Endowment for School of Pharmacy
10. Lilly Statement Regarding President Obamas Meeting With U.S. Business Leaders
11. Lilly Suspends Phase III Trial in Metastatic Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... -- Perrigo Company plc ("Perrigo") (NYSE: PRGO ; TASE) ... leading OTC brands from GSK in an all cash ... clear demonstration of Perrigo,s unique ability to maximize brand ... 36 countries.  Perrigo Chairman, President and ... excited to complete this transaction, which clearly demonstrates our ...
(Date:8/28/2015)... LONDRES, 28 de agosto de 2015   ... su participación en el  Congreso de la ESC ... más recientes y novedosas, entre ellas HeartModel A.I. ... las personas y la tecnología con los protocolos ... guiar los tratamientos y permitir atención en el ...
(Date:8/27/2015)... CUPERTINO, Calif. , Aug. 27, 2015 ... management is scheduled to present at three upcoming healthcare ... , President and CEO, will present at the Rodman ... 10:00 a.m. Eastern time. The conference is being held ... York City . A live audio webcast of ...
Breaking Medicine Technology:Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5DURECT to Participate in Upcoming Healthcare Conferences 2
... THE WOODLANDS, Texas, Dec. 7, 2010 Community-based oncology practices ... iKnowMed PM. iKnowMed PM is offered by US Oncology, ... accessible via the Internet and customizable for community-based oncology practices. ... and can interface with a variety of other EHRs already ...
... Dec. 7, 2010 MedAvante, Inc., the leader in ... disorders, announced that Cipher Pharmaceuticals is using MedAvante Centralized ... Cipher recently announced the completion of the ... every patient is interviewed by a qualified MedAvante mental ...
Cached Medicine Technology:Community-Based Oncology Practices Have a New Affordable Practice Management System Offering by US Oncology 2Community-Based Oncology Practices Have a New Affordable Practice Management System Offering by US Oncology 3Community-Based Oncology Practices Have a New Affordable Practice Management System Offering by US Oncology 4Cipher Pharmaceuticals Using MedAvante Centralized Ratings in Phase 3 Study 2Cipher Pharmaceuticals Using MedAvante Centralized Ratings in Phase 3 Study 3
(Date:8/30/2015)... ... August 31, 2015 , ... The acknowledgement from Caribbean Journal comes after Grace ... 2015. The island of Providenciales itself received a TripAdvisor Traveller's Choice Award in ... Bay is offering a special promotion for newlyweds and honeymooners to celebrate this amazing ...
(Date:8/30/2015)... ... August 31, 2015 , ... ChopChop Kids, ... for Kids , recently elected two new officers to serve on the organization’s ... mission of inspiring and teaching kids to cook real food with their families ...
(Date:8/30/2015)... CA (PRWEB) , ... August 30, 2015 , ... ... announced a back to school special. The company is currently offering lice head checks ... In addition, the company is offering a 10% discount on their lice treatment products. ...
(Date:8/30/2015)... ... August 30, 2015 , ... Certified Nutrition Businessman Reid Eckert agrees to ... InHealth media is a global sales and communications firm that offers U.S. brands a ... our business relationship with Mr. Reid Eckert, as his interpretation of the nutritional needs ...
(Date:8/29/2015)... Tempe, AZ (PRWEB) , ... August 30, 2015 , ... ... of David O’Shea to serve as the college’s Vice President of Strategic Initiatives and ... years, is eager to help the college expand its reach and impact through innovative ...
Breaking Medicine News(10 mins):Health News:Grace Bay Beach Named a Top Beach Destination for Weddings 2Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 2Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 3Health News:Lizzie’s Lice Pickers Announces Back to School Head Check Special and Discounted Lice Treatment Products 2Health News:Nutrition Guru Continues Relationship With Renowned Health and Wellness Company 2Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2
... By Steven Reinberg HealthDay Reporter , MONDAY, Oct. ... appear to reduce the risk of having a baby with a ... or palette, a new study suggests. Neural tube birth ... are known to decrease when pregnant women take supplements of folic ...
... strength of its synapses -- the connections between neurons -- ... discovery that challenges conventional wisdom on the brain mechanisms of ... "rhythm," or frequency, for changing synaptic strength. And further, like ... a different optimal frequency for learning. The ...
... Mount Sinai School of Medicine have found that $6.7 billion ... unnecessary medications in primary care, with 86 percent of that ... high cholesterol. The findings are published in a research letter ... of Internal Medicine , one of the JAMA/Archives journals. ...
... By Amanda Gardner HealthDay Reporter , MONDAY, ... 10 parents don,t follow recommended vaccination guidelines for their ... involve skipping doses or delaying shots. And parents ... move toward an alternative schedule, according to new research. ...
... , MONDAY, Oct. 3 (HealthDay News) -- Among patients ... of sedation was not linked to an increased risk ... Swedish researchers report. "Neither duration of anesthesia nor ... with an increased risk for new malignant disease within ...
... whether or not to treat an ill resident on-site or send ... status. A new study out this month shows that on ... be sent to the hospital than individuals with private insurance ... health outcomes. "Nursing homes have an incentive to ...
Cached Medicine News:Health News:Mom's Healthy Diet Might Cut Birth Defect Risk 2Health News:Mom's Healthy Diet Might Cut Birth Defect Risk 3Health News:How the brain makes memories: Rhythmically! 2Health News:How the brain makes memories: Rhythmically! 3Health News:New research shows $6.7 billion spent on unnecessary tests and treatments in one year 2Health News:Some U.S. Parents Ignoring Vaccination Guidelines 2Health News:Some U.S. Parents Ignoring Vaccination Guidelines 3Health News:General Anesthesia Does Not Boost Cancer Risk, Study Finds 2Health News:Nursing home hospitalizations often driven by payer status 2Health News:Nursing home hospitalizations often driven by payer status 3Health News:Nursing home hospitalizations often driven by payer status 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: